USA flag logo/image

An Official Website of the United States Government

ANTI-ANGIOGENIC PEPTIDES DERIVED FROM HUMAN KININOGEN

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
45750
Program Year/Program:
1999 / SBIR
Agency Tracking Number:
1R43CA083536-01
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ANGSTROM PHARMACEUTICALS, INC.
11585 SORRENTO VALLEY RD/STE 105 SAN DIEGO, CA 92121
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1999
Title: ANTI-ANGIOGENIC PEPTIDES DERIVED FROM HUMAN KININOGEN
Agency: HHS
Contract: N/A
Award Amount: $100,017.00
 

Abstract:

Not Available Accurate Automation Corporation (AAC) and AMT USA proposes to develop a detailed survey and performance trade study of jet turbine engines currently available by the remotely controlled (RC) aircraft industry and perform preliminary ground testing on a baseline turbine engine. In addition, AAC proposes to perform conceptual design improvements and develop a test plan to validate un-installed and installed engine performance on the baseline engine. The proposed Phase I program includes a detailed analysis of current RC turbine engines, an engine ground test for performance evaluation and integration requirements, a conceptual engine design modification plan, and an advanced engine test plan designed to characterize the baseline engine performance. A second-generation turbine engine will be manufactured, ground tested, and perhaps even flight tested in Phase II on an AAC unmanned aerial vehicle (UAV).

Principal Investigator:

Andrew P. Mazar

Business Contact:


6193501760
JONES@ANGSTROMINC.COM
Small Business Information at Submission:

ANGSTROM PHARMACEUTICALS, INC.
11585 SORRENTO VALLEY RD/STE 105 SAN DIEGO, CA 92121

EIN/Tax ID: 330691094
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No